Cargando…

Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Shukla, Akhil, Wong, David, Humphries, Julie A., Fitzgerald, Benjamin T., Newbigin, Katrina, Bashford, John, Scalia, Gregory M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Advancing in Amyloidosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034454/ https://www.ncbi.nlm.nih.gov/pubmed/30062242 http://dx.doi.org/10.1016/j.case.2017.01.012

Ejemplares similares

Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain
por: Fitzgerald, Benjamin T., et al.
Publicado: (2017)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors
por: Fitzgerald, Benjamin Thomas, et al.
Publicado: (2017)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
por: Aimo, Alberto, et al.
Publicado: (2022)

Cardiac transthyretin amyloidosis (99m)Tc-DPD SPECT correlates with strain echocardiography and biomarkers
por: Löfbacka, Viktor, et al.
Publicado: (2020)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

An Autopsy Case of Cardiac Amyloidosis with Heterogeneous Deposition of Amyloid Protein: A Possible Mechanism for Relative Apical Sparing of Longitudinal Strain
por: Sawada, Naoko, et al.
Publicado: (2019)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
por: Patel, Rishi K., et al.
Publicado: (2022)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value
por: Cipriani, Alberto, et al.
Publicado: (2022)

Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
por: Schatka, Imke, et al.
Publicado: (2021)

Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021)

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
por: Minnema, Monique C., et al.
Publicado: (2022)

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Microcalcification and (99m)Tc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis
por: Mori, Atsushi, et al.
Publicado: (2023)

Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
por: Di Bella, Gianluca, et al.
Publicado: (2015)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

1-hour versus 3-hour (99m)Tc-PYP imaging to evaluate suspected cardiac transthyretin amyloidosis
por: Nichols, Kenneth J., et al.
Publicado: (2023)

Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022)

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis
por: Moody, William E., et al.
Publicado: (2023)

Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
por: Manrique, Alain, et al.
Publicado: (2019)

Pitfalls of the Semi-Quantitative Analyzing (99m)Tc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution
por: Zhu, Yuankai, et al.
Publicado: (2022)

Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients
por: Monfort, Astrid, et al.
Publicado: (2022)

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
por: Rauf, Muhammad Umaid, et al.
Publicado: (2023)

Noninvasive diagnosis of hereditary transthyretin-related cardiac amyloidosis: A case report
por: Qin, Jin, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
por: Pilebro, Björn, et al.
Publicado: (2016)

Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
por: Minutoli, Fabio, et al.
Publicado: (2015)

Incidentally detected cardiac amyloidosis on (99m)Tc-MDP bone scintigraphy
por: Fathala, Ahmed
Publicado: (2020)

Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

Deep learn-based computer-assisted transthoracic echocardiography: approach to the diagnosis of cardiac amyloidosis
por: Zhang, Xiaofeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_32vgocjjg7co1on3pv52hmedl3